I. Krämer

发表

Prospective, systematically recorded mycophenolate safety data in Graves’ orbitopathy

G. Kahaly, A. Kuhn, M. Riedl, 2016, Journal of Endocrinological Investigation.

Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves’ orbitopathy

G. Kahaly, M. Riedl, I. Krämer, 2015, Journal of Endocrinological Investigation.

C. Ronco, B. Strukelj, D. Crommelin, 2005, Contributions to nephrology.

Lesser-known or hidden reservoirs of infection and implications for adequate prevention strategies: Where to look and what to look for

Irene Krämer, Hans-Curt Flemming, Philippe Hartemann, 2015, GMS hygiene and infection control.

Use of quantitative microbiological analyses to trace origin of contamination of parenteral nutrition solutions

M. Exner, S. Bhakdi, E. Siegel, 2012, Medical Microbiology and Immunology.

Physicochemical compatibility and stability of nebulizable drug admixtures containing Dornase alfa and tobramycin.

I. Krämer, W. Kamin, A. Klemmer, 2014, Pulmonary pharmacology & therapeutics.

Viability of Selected Microorganisms in Non-Cytotoxic Aseptic Preparations

I. Krämer, I. Sarakbi, R. M. Heeb, 2016 .

In-use physicochemical and microbiological stability of biological parenteral products.

W. J. Galush, M. Cromwell, U. Grauschopf, 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Stability of irinotecan-loaded drug eluting beads (DC BeadTM) used for transarterial chemoembolization

I. Krämer, J. Thiesen, Jeanette Kaiser, 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Longterm physicochemical stability of ready-to-administer human insulin injection solutions 1 I.U./mL in 50 mL plastic syringes

André Mohr, I. Krämer, F. Erdnüss, 2022, Pharmaceutical Technology in Hospital Pharmacy.

Loading, release and stability of epirubicin-loaded drug-eluting beads

I. Krämer, J. Thiesen, K. Spindeldreier, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Denosumab (XGEVA): assessment from a pharmacist's perspective

I. Krämer, 2013 .

Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application

G. Kahaly, I. Krämer, Jan Längericht, 2020, Therapeutic advances in endocrinology and metabolism.

Inhalation solutions--which ones may be mixed? Physico-chemical compatibility of drug solutions in nebulizers--update 2013.

I. Krämer, W. Kamin, F. Erdnüss, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Inhalationsolutions—Whichonesmaybemixed?Physico-chemical compatibilityofdrugsolutionsinnebulizers—Update2013

I. Krämer, W. Kamin, F. Erdnüss, 2014 .

Physicochemical compatibility of mixtures of dornase alfa and tobramycin containing nebulizer solutions

R. Lichtinghagen, I. Krämer, W. Kamin, 2009, Pediatric pulmonology.

Physicochemical compatibility of fluticasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions

I. Krämer, W. Kamin, A. Schwabe, 2007, International journal of chronic obstructive pulmonary disease.

Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.

I. Krämer, W. Kamin, A. Schwabe, 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Loading profile of topotecan into polyvinyl alcohol microspheres (DC Bead™) over a 7-day period

I. Krämer, Jeanette Kaiser, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Pharmacokinetics of Piperacillin and Ciprofloxacin in Critically Ill Patients Undergoing Continuous Venovenous Haemodialysis or Haemodiafiltration

K. Engelhard, M. Bodenstein, I. Krämer, 2014 .

Intravenous and oral antibiotics in respiratory tract infection: an international observational study of hospital practice

J. Cooke, T. Morris, I. Krämer, 2002, Pharmacy World and Science.

Physicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bags

I. Krämer, J. Thiesen, 2000 .

Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices

I. Krämer, J. Thiesen, 1999 .

Multi-center observational study on the adherence, quality of life, and adverse events in lung cancer patients treated with tyrosine kinase inhibitors

I. Krämer, J. Stratmann, J. Alt, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Physico‐chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers

I. Krämer, J. Thiesen, 1999, Pharmacy World and Science.

Drug safety in thyroid eye disease – a systematic review

A. Hubalewska-Dydejczyk, G. Kahaly, I. Krämer, 2022, Expert opinion on drug safety.

Plasticizer extraction of Taxol®-infusion solution from various infusion devices

C. Huber, I. Krämer, B. Maas, 1996, Pharmacy World and Science.

Aerosolization Performance of Jet Nebulizers and Biopharmaceutical Aspects

G. Colombo, I. Krämer, F. Buttini, 2019, Pharmaceutics.

Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.

I. Krämer, W. Kamin, A. Wollstadt, 2013, Die Pharmazie.

A Liquid Chromatography Assay for the Simultaneous Quantification of Piperacillin and Ciprofloxacin in Human Plasma and Dialysate in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

I. Krämer, F. Scheer, 2014 .

Bevacizumab, a humanized anti‐angiogenic monoclonal antibody for the treatment of colorectal cancer

H. Lipp, I. Krämer, 2007, Journal of clinical pharmacy and therapeutics.

Development of a HPLC-system for quantitative measurement of lidocaine and bupivacaine in patients plasma during postoperative epidural pain therapy.

W. Dick, I. Krämer, J. Jage, 1995, Die Pharmazie.

Use of quantitative microbiological analyses to trace origin of contamination of parenteral nutrition solutions

M. Exner, S. Bhakdi, E. Siegel, 2012, Medical Microbiology and Immunology.

The new world of biosimilars: what diabetologists need to know about biosimilar insulins:

I. Krämer, Thomas Sauer, 2010 .

Busulfan systemic exposure after oral administration of extemporeanously prepared high-dose busulfan capsules

I. Krämer, K. Kolbe, A. Karstens, 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media

I. Krämer, I. Sarakbi, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.

I. Krämer, M. Federici, 2018, European journal of hospital pharmacy : science and practice.

Efficacy of four cleaning solutions for the decontamination of selected cytotoxic drugs on the different surfaces of an automated compounding system

R. Schierl, I. Krämer, D. Paolucci, 2019, Journal of occupational and environmental hygiene.

Environmental and Product Contamination during the Preparation of Antineoplastic Drugs with Robotic Systems

R. Schierl, I. Krämer, M. Federici, 2018, Pharmaceutical Technology in Hospital Pharmacy.

In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion

André Mohr, I. Krämer, 2020, European journal of hospital pharmacy : science and practice.

How to select a biosimilar

R. Janknegt, A. Vulto, I. Krämer, 2013 .

Cytotoxic surface contamination in a robotic system compared with manual preparation

I. Krämer, B. Gandré, 2012 .

Assessing the risk to health care staff from long-term exposure to anticancer drugs - the case of monoclonal antibodies

I. Krämer, G. Halsen, 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Pharmacy and pharmacology of biosimilars

I. Krämer, 2008, Journal of endocrinological investigation.

A NOVEL MONOCLONAL ANTIBODY DEGRADES THE THYROTROPIN RECEPTOR AUTOANTIBODIES IN GRAVES' DISEASE.

I. Krämer, Jan Wolf, G. Kahaly, 2023, Endocrine Practice.

Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions

I. Krämer, J. Kaiser, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period

S. H. Kim, I. Krämer, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.

R. Lichtinghagen, I. Krämer, W. Kamin, 2007, Die Pharmazie.

Formulation and Administration of Biological Medicinal Products”

Irene Krämer, Judith Thiesen, Alain Astier, 2020, Pharmaceutical Research.

Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags

I. Krämer, J. Kaiser, 2011 .

Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions

H. Lipp, I. Krämer, J. Thiesen, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes

I. Krämer, J. Thiesen, M. Federici, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Compatibility of amsacrine (Amsidyl®) concentrate for infusion with polypropylene syringes

I. Krämer, B. Maas, 1999 .

European Databases on Stability and Compatibility of Injectable Medicinal Products in Europe

J. Vigneron, I. Krämer, J. Hecq, 2019, Pharmaceutical Technology in Hospital Pharmacy.

Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL)

I. Krämer, J. Thiesen, F. Erdnüss, 2023, Pharmaceutical Technology in Hospital Pharmacy.

Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment

I. Krämer, J. Thiesen, H. Linxweiler, 2023, Pharmaceutics.

Viability of microorganisms in novel antineoplastic and antiviral drug solutions

I. Krämer, 1998 .

Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine.

I. Krämer, J. Jage, A. Sattler, 1998, Die Pharmazie.

Long-term stability of ready-to-use epinephrine 0.02 mg/mL injection solution in 50 mL glass vials

I. Krämer, R. M. Heeb, F. Erdnüss, 2022, Pharmaceutical Technology in Hospital Pharmacy.

Stability of Ready-to-Administer and Ready-to-Use Epinephrine and Norepinephrine Injection Solutions

I. Krämer, R. M. Heeb, J. Thiesen, 2017 .

Significant interaction between high-dose methotrexate and high-dose piperacillin-tazobactam causing reversible neurotoxicity and renal failure in an osteosarcoma patient

I. Krämer, M. Kühn, Jelena Rosentreter, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Physicochemical stability of cabazitaxel containing premix solution and diluted infusion solutions

I. Krämer, J. Thiesen, K. Spindeldreier, 2015 .

Focused physicochemical stability study of reconstituted trastuzumab biosimilar SB3 (Ontruzant®) stored in the original vials over 28 days

I. Krämer, J. Thiesen, Laura Knoll, 2024, Pharmaceutical Technology in Hospital Pharmacy.

Physicochemical stability of durvalumab (Imfinzi®) concentrate for solution in original vials after first opening

I. Krämer, J. Thiesen, Jannik Almasi, 2023, Pharmaceutical Technology in Hospital Pharmacy.

Requirements concerning antiseptics for periorbital, orbital and intraorbital application. Formulation requirements for the ophthalmic use of antiseptics.

I. Krämer, M. Haber, A. Duis, 2002, Developments in ophthalmology.